AHL
RXRX icon

Abel Hall LLC’s Recursion Pharmaceuticals RXRX Stock Holding History

Abel Hall LLC’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$48.5K Buy
+13,205
New +$44K 0.01% 897

Other funds holding RXRX

Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
1WA
180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return
BEI
Benjamin Edwards Inc Clayton, Missouri $11B AUM 18.22% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
SFS
Sowell Financial Services North Little Rock, Arkansas $3.06B AUM 30.02% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
KG
Kieckhefer Group Mequon, Wisconsin $246M AUM 51.29% 1-Year Est. Return
TMC
Themes Management Co Greenwich, Connecticut $151M AUM

Abel Hall LLC's RXRX Position: Q2 2026 in Review

Abel Hall LLC opened a new position in Recursion Pharmaceuticals (RXRX) in Q2 2026: 13,205 shares worth $48.5K. The stake represents 0.01% of the portfolio and ranks #897 among its holdings.

78 funds tracked by Wall St. Rank hold RXRX as of Q2 2026.

  • Abel Hall LLC held 13,205 shares of Recursion Pharmaceuticals worth $48.5K as of Q2 2026.
  • Recursion Pharmaceuticals was a new Abel Hall LLC position in Q2 2026.
  • Recursion Pharmaceuticals made up 0.01% of Abel Hall LLC's portfolio in Q2 2026, its #897 holding.
  • 78 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q2 2026.

Based on Abel Hall LLC's 13F filing for Q2 2026, filed 24 Jul 2026.